SCHEMBL7668231

SCHEMBL7668231

O=C(Nc1ccc(C=Cc2ccc(NC(=O)c3ccc(N4CCOCC4)c(S(=O)(=O)N4CCOCC4)c3)cc2S(=O)(=O)O)c(S(=O)(=O)O)c1)c1ccc(N2CCOCC2)c(S(=O)(=O)N2CCOCC2)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.63
MAPT P10636 4/20 0.63
KDM4E B2RXH2 2/20 0.63
HPGD P15428 2/20 0.63
MEN1 O00255 6/20 0.58
KMT2A Q03164 6/20 0.58
LMNA P02545 7/20 0.58
SMN1; SMN2 Q16637 5/20 0.58
MAPK1 P28482 4/20 0.58
HTT P42858 2/20 0.58
TSHR P16473 4/20 0.56
ATM Q13315 1/20 0.53
CNR1 P21554 2/20 0.52
CNR2 P34972 2/20 0.52
TP53 P04637 2/20 0.52
USP2 O75604 1/20 0.52
GAA P10253 1/20 0.52
HSD17B10 Q99714 1/20 0.52
NPC1 O15118 2/20 0.52
RAB9A P51151 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7668133 1.00 ALDH1A1 (0.63) ALDH1A1MAPTKDM4EHPGDMEN1
SCHEMBL7666246 0.87 LMNA (0.56) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL7666320 0.87 LMNA (0.56) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL7690986 0.87 ALDH1A1 (0.66) ALDH1A1MAPTKDM4EHPGDMEN1
SCHEMBL7661372 0.85 SMN1; SMN2 (0.56) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL7666465 0.85 KMT2A (0.68) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL7669766 0.85 LMNA (0.55) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL7666544 0.85 KMT2A (0.68) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL7669689 0.85 LMNA (0.55) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL7661298 0.85 SMN1; SMN2 (0.56) ALDH1A1MAPTHPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020111369-A1 Aryl sulfonic acids and derivatives as FSH antagonists AMERICAN HOME PRODUCTS CORPORATION (US) 2002-08-15 US claimed
WO-2000058277-A1 ARYL SULFONIC ACIDS AND DERIVATIVES AS FSH ANTAGONISTS AMERICAN HOME PRODUCTS CORPORATION (US) 2000-10-05 WO claimed
US-20020111369-A1 Aryl sulfonic acids and derivatives as FSH antagonists AMERICAN HOME PRODUCTS CORPORATION (US) 2002-08-15 US disclosed
US-6355633-B1 CONTRACEPTIVES AMERICAN HOME PRODUCTS CORPORATION 2002-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020111369-A1 Aryl sulfonic acids and derivatives as FSH antagonists FSHR, GNRHR, LHCGR ALDH1A1 3990/4885MAPT 4858/4885KDM4E 2287/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.